Valeria R. Martinez

Valeria R. Martinez

Auto-generated profile, based on publicly available information

Valeria R. Martinez

CIC–CONICET-UNLP Facultad de Médicas Universidad Nacional de La Plata 60 y 120 1900 La Plata Argentina

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
LNLuciana Naso
Luciana Naso
VMValeria R. Martínez
Valeria R. Martínez
LLLuis Lezama
Luis Lezama
CSClarisa Salado
Clarisa Salado
MVMaría Valcarcel
María Valcarcel
PWPatricia A.M. Williams
Patricia A.M. Williams

1 April 2018 in Toxicology in Vitro
Verified
Journal Article
Closed access
VMValeria R. Martínez
Valeria R. Martínez
MAMaría V. Aguirre
María V. Aguirre
JTJuan S. Todaro
Juan S. Todaro
OPOscar E. Piro
Oscar E. Piro
GEGustavo A. Echeverría
Gustavo A. Echeverría
PWPatricia A.M. Williams
Patricia A.M. Williams

12 April 2018 in Biological Trace Element Research
Verified
Journal Article
Closed access
PDF file
VMValeria R. Martínez
Valeria R. Martínez
MAMaría V. Aguirre
María V. Aguirre
JTJuan S. Todaro
Juan S. Todaro
OPOscar E. Piro
Oscar E. Piro
GEGustavo A. Echeverría
Gustavo A. Echeverría
PWPatricia A.M. Williams
Patricia A.M. Williams

1 March 2021 in Journal of Trace Elements in Medicine and Biology
Verified
Journal Article
Closed access
LNLuciana G. Naso
Luciana G. Naso
VMValeria R. Martínez
Valeria R. Martínez
EFEvelina Ferrer
Evelina Ferrer
PWPatricia A.M. Williams
Patricia A.M. Williams

27 November 2020 in Future Medicinal Chemistry
Verified
Journal Article
Closed access
VMValeria R Martínez
Valeria R Martínez
MAMaría Aguirre
María Aguirre
JTJuan S Todaro
Juan S Todaro
Augusto Martins LimaAugusto Martins Lima
Augusto Martins Lima
NSNikolaos Stergiopulos
Nikolaos Stergiopulos
PWPatricia A.M. Williams
Patricia A.M. Williams
Background: Angiotensin II receptor blockers were designed as therapeutic agents to block the binding site of the angiotensin II receptor type 1 (AT1R). Methodology: The structure of telmisartan wa... Graphical abstract

7 January 2025 in Chempluschem
Verified
Journal Article
Closed access
ADAgustin B. Actis Dato
Agustin B. Actis Dato
Luciana NasoLuciana Naso
Luciana Naso
VMValeria R. Martínez
Valeria R. Martínez
EFEvelina Ferrer
Evelina Ferrer
PWPatricia A.M. Williams
Patricia A.M. Williams